DDR1 and B-cell non-Hodgkin lymphoma: We validated an antibody specific for CENPE protein (Figure S6A) and used this to show that CENPE protein levels were decreased by collagen treatment of the DDR1‐expressing B‐cell lymphoma lines (Figure 5D) and by expression of a constitutively activated DDR1 construct (Figure 5E).